ÀֳȳɾÍÈËÉú

ÎÂÒ½Ö÷Ò³  
ÄúÏÖÔÚµÄλÖÃÊÇ£ºÎÂÖÝÒ½¿Æ´óѧÐÂÎÅÖÐÐÄ >> ѧÊõ¶¯Ì¬
ѧÊõ¶¯Ì¬
  •  Ò½´óѧ×Ó¿ÆÑгɹû»ñÊÀ½ç´óѧÉúÒ©Ô·ÂÛ̳´´ÐÂÐÔʵÑé³É¹ûÀàÒ»µÈ½±
  • ×÷ÕߣºÐÜС½¨ »ÆÎÄ   À´Ô´£ºÒ©Ñ§Ôº£¨·ÖÎö²âÊÔÖÐÐÄ£©   ±à¼­£ºÎâ•FÔ   ä¯ÀÀ£º20958
  • ½üÈÕ£¬ÓɽÌÓý²¿¸ßµÈÀֳȳɾÍÈËÉúҩѧÀàרҵ½Ìѧָµ¼Î¯Ô±»á¡¢Öйúҩѧ»áҩѧ½ÌÓýרҵίԱ»áÖ÷°ì£¬ÖйúÒ©¿Æ´óѧ³Ð°ìµÄÊ×½ìÈ«Çòҩѧ½ÌÓý»áÒé¡¢2016ÊÀ½ç´óѧÉúÒ©Ô·ÂÛ̳ôߵھŽìÈ«¹ú´óѧÉúÒ©Ô·ÂÛ̳ÔÚ½­ËÕÄϾ©¾ÙÐС£ÂÛ̳ÉÏ£¬ÎÒУҩѧԺ2014¼¶±¾¿ÆÉúÇñ³¿ÓîµÄ¿ÆÑÐÏîÄ¿¡¶Synthesis and biological evaluation of allylated mono-carbonyl curcumin analogues (MACs) as anti-cancer agents for cholangiocarcinoma¡·£¨Éè¼Æ¡¢ºÏ³ÉÏ©±û»ùµ¥ôÊ»ù½ª»ÆËØÀàËÆÎï¼°Æ俹µ¨¹Ü°©Ò©Àí»îÐÔÑо¿£©ÈÙ»ñ´´ÐÂÐÔʵÑé³É¹ûÀàÒ»µÈ½±£¬²¢Í¬Ê±ÈÙ»ñÓÅÐãÂÛÎĽ±¡£

    ¸Ã¿ÆÑÐÏîÄ¿ÒÔÀ´Ô´ÓÚ´«Í³ÖÐÒ©½ª»ÆµÄÖ÷Òª³É·Ö¡ª¡ª½ª»ÆËØΪҩÎïÏȵ¼£¬ÔÚÈ¥³ý¿Éµ¼Ö½ª»ÆËØ´úл¿ì¡¢ÉúÎïÀûÓöȵ͵ÄË«ôÊ»ùºÍÑǼ׻ù£¬Í¬Ê±ÒýÈëµ¥ôÊ»ù¼°»îÐÔÏ©±û»ùµÈºóÐøµÄ½á¹¹ÐÞÊΡ¢¸ÄÔì²ßÂÔÖ®ºó£¬·¢ÏÖÁËһϵÁнṹÎȶ¨µÄ½ª»ÆËØÀàËÆÎï¡£¾­½øÒ»²½µÄÉúÎï»îÐÔɸÑ¡£¬·¢ÏÖÕâЩÀàËÆÎï¾ßÓÐÁ¼ºÃµÄ¿¹µ¨¹Ü°©Ò©Àí×÷Ó㬿É×÷ΪºóÐø¿¹Ö×ÁöÒ©Î↑·¢µÄÏȵ¼¡£

    ¾ÝϤ£¬Ê×½ìÈ«Çòҩѧ½ÌÓý»áÒéÊǹú¼ÊҩѧÁªºÏ»á¡¶Ò©Ñ§½ÌÓý5ÄêÐж¯¼Æ»®¡·ºËÐĻ֮һ¡£´Ë´ÎÒÔ¡°·¢ÏÖÃ÷ÈÕҩѧ֮ÐÇ£¬¹¹½¨Ò©Ñ§ÉúÈ«ÇòÊÓÒ°¡±ÎªÖ÷ÌâµÄ»áÒ飬ÎüÒýÁËÀ´×Ôº£ÄÚÍâ84ËùÖªÃûԺУµÄ500ÓàÃûʦÉú£¬ÊÕµ½´óѧÉú´´ÐÂʵÑéÑо¿ÏîÄ¿ÂÛÎÄ100Óàƪ¡£¾­¹ý˫äÂÛÎÄÆÀÉó¡¢Ñ§ÉúÏÖ³¡´ð±ç¡¢ÂÛ̳ίԱ»áÆÀÒéµÈ»·½Ú£¬»áÒé¹²ÆÀ³öÒ»µÈ½±17Ï¶þµÈ½±26ÏÈýµÈ½±41Ïî¼°ÓÅÐãÂÛÎĽ±17Ïî¡£

    ɨһɨÔÚÊÖ»ú´ò¿ªµ±Ç°Ò³

  • ·ÖÏíµ½£º
Ïà¹ØÐÂÎÅ£º
ÔÝʱûÓÐÕÒµ½Ïà¹ØÐÂÎÅ£¡
°æȨËùÓУºÎÂÖÝÒ½¿Æ´óѧµ³Î¯Ðû´«²¿ Î´¾­Ðí¿É£¬ÇëÎðתÔØ
  ¼¼ÊõÖ§³Ö£ºÂóÍؿƼ¼
ÀֳȳɾÍÈËÉú - v6.6.18 - IOS/Android/Æ»¹û/°²×¿